• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移动和可穿戴技术在糖尿病相关参数监测中的应用:系统评价。

Mobile and Wearable Technology for the Monitoring of Diabetes-Related Parameters: Systematic Review.

机构信息

Research Center for Information and Communication Technologies, University of Granada, Granada, Spain.

Department of Computer Science, University of Cienfuegos, Cienfuegos, Cuba.

出版信息

JMIR Mhealth Uhealth. 2021 Jun 3;9(6):e25138. doi: 10.2196/25138.

DOI:10.2196/25138
PMID:34081010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8212630/
Abstract

BACKGROUND

Diabetes mellitus is a metabolic disorder that affects hundreds of millions of people worldwide and causes several million deaths every year. Such a dramatic scenario puts some pressure on administrations, care services, and the scientific community to seek novel solutions that may help control and deal effectively with this condition and its consequences.

OBJECTIVE

This study aims to review the literature on the use of modern mobile and wearable technology for monitoring parameters that condition the development or evolution of diabetes mellitus.

METHODS

A systematic review of articles published between January 2010 and July 2020 was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Manuscripts were identified through searching the databases Web of Science, Scopus, and PubMed as well as through hand searching. Manuscripts were included if they involved the measurement of diabetes-related parameters such as blood glucose level, performed physical activity, or feet condition via wearable or mobile devices. The quality of the included studies was assessed using the Newcastle-Ottawa Scale.

RESULTS

The search yielded 1981 articles. A total of 26 publications met the eligibility criteria and were included in the review. Studies predominantly used wearable devices to monitor diabetes-related parameters. The accelerometer was by far the most used sensor, followed by the glucose monitor and heart rate monitor. Most studies applied some type of processing to the collected data, mainly consisting of statistical analysis or machine learning for activity recognition, finding associations among health outcomes, and diagnosing conditions related to diabetes. Few studies have focused on type 2 diabetes, even when this is the most prevalent type and the only preventable one. None of the studies focused on common diabetes complications. Clinical trials were fairly limited or nonexistent in most of the studies, with a common lack of detail about cohorts and case selection, comparability, and outcomes. Explicit endorsement by ethics committees or review boards was missing in most studies. Privacy or security issues were seldom addressed, and even if they were addressed, they were addressed at a rather insufficient level.

CONCLUSIONS

The use of mobile and wearable devices for the monitoring of diabetes-related parameters shows early promise. Its development can benefit patients with diabetes, health care professionals, and researchers. However, this field is still in its early stages. Future work must pay special attention to privacy and security issues, the use of new emerging sensor technologies, the combination of mobile and clinical data, and the development of validated clinical trials.

摘要

背景

糖尿病是一种代谢紊乱疾病,影响着全球数亿人,并导致每年数百万人死亡。这种戏剧性的情况给行政部门、护理服务和科学界带来了一些压力,促使他们寻求新的解决方案,以帮助控制和有效应对这种疾病及其后果。

目的

本研究旨在回顾关于使用现代移动和可穿戴技术监测影响糖尿病发生或发展的参数的文献。

方法

根据 PRISMA(系统评价和荟萃分析的首选报告项目)指南,对 2010 年 1 月至 2020 年 7 月期间发表的文章进行了系统综述。通过搜索 Web of Science、Scopus 和 PubMed 数据库以及手工搜索来确定手稿。如果手稿涉及通过可穿戴或移动设备测量与糖尿病相关的参数,例如血糖水平、进行身体活动或脚部状况,则将其纳入研究。使用纽卡斯尔-渥太华量表评估纳入研究的质量。

结果

搜索结果得到 1981 篇文章。共有 26 篇出版物符合入选标准并纳入综述。研究主要使用可穿戴设备来监测与糖尿病相关的参数。到目前为止,加速度计是使用最多的传感器,其次是血糖仪和心率监测器。大多数研究对收集到的数据进行了某种类型的处理,主要包括统计分析或机器学习,用于活动识别、发现健康结果之间的关联以及诊断与糖尿病相关的疾病。很少有研究关注 2 型糖尿病,即使 2 型糖尿病是最常见的也是唯一可预防的类型。几乎没有研究关注常见的糖尿病并发症。在大多数研究中,临床试验相当有限或不存在,并且通常缺乏关于队列和病例选择、可比性和结果的详细信息。大多数研究都没有明确得到伦理委员会或审查委员会的支持。隐私或安全问题很少被提及,即使被提及,也只是在相当不足的水平上被提及。

结论

使用移动和可穿戴设备监测与糖尿病相关的参数显示出早期的希望。它的发展可以使糖尿病患者、医疗保健专业人员和研究人员受益。然而,该领域仍处于早期阶段。未来的工作必须特别注意隐私和安全问题、新出现的传感器技术的使用、移动和临床数据的结合以及经过验证的临床试验的开发。

相似文献

1
Mobile and Wearable Technology for the Monitoring of Diabetes-Related Parameters: Systematic Review.移动和可穿戴技术在糖尿病相关参数监测中的应用:系统评价。
JMIR Mhealth Uhealth. 2021 Jun 3;9(6):e25138. doi: 10.2196/25138.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
6
Evaluating the Validity and Utility of Wearable Technology for Continuously Monitoring Patients in a Hospital Setting: Systematic Review.评估可穿戴技术在医院环境中连续监测患者的有效性和实用性:系统评价。
JMIR Mhealth Uhealth. 2021 Aug 18;9(8):e17411. doi: 10.2196/17411.
7
Reading aids for adults with low vision.针对视力低下成年人的阅读辅助工具。
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD003303. doi: 10.1002/14651858.CD003303.pub4.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.

引用本文的文献

1
Sensor-based evaluation of intermittent fasting regimes: a machine learning and statistical approach.基于传感器的间歇性禁食方案评估:一种机器学习与统计学方法。
Int J Obes (Lond). 2025 Aug 22. doi: 10.1038/s41366-025-01889-0.
2
The effectiveness of digital health intervention on glycemic control and physical activity in patients with type 2 diabetes: a systematic review and meta-analysis.数字健康干预对2型糖尿病患者血糖控制和身体活动的有效性:一项系统评价和荟萃分析。
Front Digit Health. 2025 Jul 29;7:1630588. doi: 10.3389/fdgth.2025.1630588. eCollection 2025.
3
Progress in the management of type 2 diabetes mellitus: a narrative review of telerehabilitation and wearable devices.

本文引用的文献

1
Driving Safety and Real-Time Glucose Monitoring in Insulin-Dependent Diabetes.胰岛素依赖型糖尿病患者的驾驶安全与实时血糖监测
Int J Automot Eng. 2019;10(1):34-40. doi: 10.20485/jsaeijae.10.1_34. Epub 2019 Feb 4.
2
7. Diabetes Technology: .7. 糖尿病技术:。
Diabetes Care. 2020 Jan;43(Suppl 1):S77-S88. doi: 10.2337/dc20-S007.
3
Examining the Use of Glucose and Physical Activity Self-Monitoring Technologies in Individuals at Moderate to High Risk of Developing Type 2 Diabetes: Randomized Trial.检查葡萄糖和身体活动自我监测技术在 2 型糖尿病高危人群中的应用:随机试验。
2型糖尿病管理的进展:远程康复与可穿戴设备的叙述性综述
Ann Pediatr Endocrinol Metab. 2025 Apr;30(2):69-76. doi: 10.6065/apem.2448162.081. Epub 2025 Apr 30.
4
Patient Adherence for Oral Combination Therapies in Diabetes Management: A Scoping Review.糖尿病管理中口服联合疗法的患者依从性:一项范围综述
Health Sci Rep. 2025 Apr 29;8(5):e70780. doi: 10.1002/hsr2.70780. eCollection 2025 May.
5
Impact of machine learning on dietary and exercise behaviors in type 2 diabetes self-management: a systematic literature review.机器学习对2型糖尿病自我管理中饮食和运动行为的影响:一项系统文献综述
PeerJ Comput Sci. 2025 Feb 3;11:e2568. doi: 10.7717/peerj-cs.2568. eCollection 2025.
6
Diagnostic accuracy of ECG smart chest patches versus PPG smartwatches for atrial fibrillation detection: a systematic review and meta-analysis.心电图智能胸贴与脉搏血氧仪智能手表检测心房颤动的诊断准确性:一项系统评价和荟萃分析。
BMC Cardiovasc Disord. 2025 Feb 25;25(1):132. doi: 10.1186/s12872-025-04582-2.
7
Wearables and Atrial Fibrillation: Advances in Detection, Clinical Impact, Ethical Concerns, and Future Perspectives.可穿戴设备与心房颤动:检测进展、临床影响、伦理考量及未来展望
Cureus. 2025 Jan 13;17(1):e77404. doi: 10.7759/cureus.77404. eCollection 2025 Jan.
8
Advanced Wearable Sensors Technologies for Healthcare Monitoring.用于医疗监测的先进可穿戴传感器技术
Sensors (Basel). 2025 Jan 8;25(2):322. doi: 10.3390/s25020322.
9
Updates on Methods for Body Composition Analysis: Implications for Clinical Practice.身体成分分析方法的更新:对临床实践的启示
Curr Obes Rep. 2025 Jan 11;14(1):8. doi: 10.1007/s13679-024-00593-w.
10
The dual challenge of diabesity: pathophysiology, management, and future directions.糖尿病性肥胖的双重挑战:病理生理学、管理及未来方向。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4891-4912. doi: 10.1007/s00210-024-03713-4. Epub 2024 Dec 16.
JMIR Mhealth Uhealth. 2019 Oct 28;7(10):e14195. doi: 10.2196/14195.
4
Utility of Big Data in Predicting Short-Term Blood Glucose Levels in Type 1 Diabetes Mellitus Through Machine Learning Techniques.大数据在通过机器学习技术预测 1 型糖尿病患者短期血糖水平中的应用。
Sensors (Basel). 2019 Oct 16;19(20):4482. doi: 10.3390/s19204482.
5
Enhanced Accuracy of Continuous Glucose Monitoring during Exercise through Physical Activity Tracking Integration.通过运动追踪集成提高运动期间连续血糖监测的准确性。
Sensors (Basel). 2019 Aug 30;19(17):3757. doi: 10.3390/s19173757.
6
Methods for combining continuously measured glucose and activity data in people with Type 2 diabetes: Challenges and solutions.2型糖尿病患者连续血糖测量与活动数据相结合的方法:挑战与解决方案
J Rehabil Assist Technol Eng. 2018 Sep 9;5:2055668318782805. doi: 10.1177/2055668318782805. eCollection 2018 Jan-Dec.
7
Big Data and diabetes: the applications of Big Data for diabetes care now and in the future.大数据与糖尿病:大数据在糖尿病护理中的现在和未来应用。
Diabet Med. 2020 Feb;37(2):187-193. doi: 10.1111/dme.14044. Epub 2019 Jul 1.
8
Artificial intelligence in healthcare.人工智能在医疗保健领域的应用。
Nat Biomed Eng. 2018 Oct;2(10):719-731. doi: 10.1038/s41551-018-0305-z. Epub 2018 Oct 10.
9
Using Passive Smartphone Sensing for Improved Risk Stratification of Patients With Depression and Diabetes: Cross-Sectional Observational Study.利用被动智能手机感应提高抑郁和糖尿病患者的风险分层:横断面观察性研究。
JMIR Mhealth Uhealth. 2019 Jan 29;7(1):e11041. doi: 10.2196/11041.
10
Comparing Real-Time Self-Tracking and Device-Recorded Exercise Data in Subjects with Type 1 Diabetes.1 型糖尿病患者实时自我追踪与设备记录运动数据的比较。
Appl Clin Inform. 2018 Oct;9(4):919-926. doi: 10.1055/s-0038-1676458. Epub 2018 Dec 26.